We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Google Shows AI Can Predict Lung Cancer from CT Scans

By HospiMedica International staff writers
Posted on 01 Jun 2019
Google LLC (Mountain View, CA, USA) has shared new research demonstrating how artificial intelligence (AI) can predict lung cancer to boost the chances of survival for people at risk across the world.

Since 2017, Google has been exploring how AI can be used to address the challenges in screening people at a high-risk for lung cancer with lower dose CT screening that leads to unclear diagnosis, subsequent unnecessary procedures, and financial costs. More...
Google used advances in 3D volumetric modeling along with datasets from its partners for modeling lung cancer prediction and laying the groundwork for future clinical testing.

Generally, radiologists go through hundreds of 2D images within a single CT scan with cancer being miniscule and hard to spot. Google researchers created a model that can generate the overall lung cancer malignancy prediction (viewed in 3D volume) as well as identify subtle malignant tissue in the lungs (lung nodules). The model can also factor in information from previous scans, which can be useful in predicting lung cancer risk as the growth rate of suspicious lung nodules can be an indicator of malignancy.

The researchers leveraged 45,856 de-identified chest CT screening cases and validated the results with a second dataset and also compared their results against six US board-certified radiologists. They found that when using a single CT scan for diagnosis, their model performed on par or better than the six radiologists and detected 5% more cancer cases while reducing false-positive exams by more than 11% as compared to unassisted radiologists in the study. Google’s approach achieved an AUC (a common metric used in machine learning that provides an aggregate measure for classification performance) of 94.4%.

With only 2-4% of eligible patients in the US being currently screened for lung cancer, Google’s research demonstrates the potential for AI to increase accuracy as well as consistency, which could help accelerate the adoption of lung cancer screening globally. Google now plans to conduct further studies to assess its impact and utility in clinical practice. It is collaborating with Google Cloud Healthcare and Life Sciences team to serve the model through the Cloud Healthcare API and is holding discussions with its partners across the world to continue additional clinical validation research and deployment.

Related Links:
Google


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Hybrid Arch Device
Neo EDE
Syringe Pump
SP50 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: Masimo smartSET pulse oximetry with PPG AFib and OIRD Detection (Photo courtesy of Masimo)

Smart Pulse Oximetry Supports Earlier Recognition of Arrhythmias and Respiratory Risk

On general care floors, respiratory compromise and arrhythmias can develop between routine checks. Atrial fibrillation often goes undiagnosed in older adults, while opioid-induced respiratory depression... Read more

Surgical Techniques

view channel
Image: 3D-printed nitinol tapered flow-diverter stent with variable fiber density, sectional size and shape. (Photo courtesy of IMDEA Materials Institute)

3D Printing Method Could Enable More Flexible Cardiovascular Implants

Minimally invasive transcatheter devices must compress into small catheters and recover their intended shape after deployment, creating a design challenge for cardiovascular implants with complex, patient-specific... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.